BioScrip to Present at BMO Capital Markets' Focus on Healthcare Conference

* Reuters is not responsible for the content in this press release.

Tue Jul 22, 2008 4:00pm EDT 

ELMSFORD, N.Y.--(Business Wire)--
BioScrip, Inc. (Nasdaq: BIOS) today announced that it will present
at the BMO Capital Markets Focus on Healthcare 2008 Investor
Conference, to be held August 5-6, 2008, at the Millennium Broadway
Hotel in New York City.

   BioScrip's Chairman and CEO, Richard H. Friedman, and Stanley G.
Rosenbaum, Executive Vice President and CFO will present Tuesday,
August 5th at 9:00 a.m. ET (Eastern Time). Investors may access the
live audio webcast of BioScrip's presentation at the following link:
http://www.bmocm.com/conferences/2008healthcare/webcast/default.aspx.
The webcast replay of the presentation may also be accessed via the
company's website at www.bioscrip.com under the Investors section.

   About BioScrip, Inc.

   BioScrip, Inc. (www.bioscrip.com) (Nasdaq: BIOS) is a specialty
pharmaceutical healthcare organization that partners with patients,
physicians, healthcare payors and pharmaceutical manufacturers to
provide access to medications and management solutions to optimize
outcomes for chronic and other complex healthcare conditions.

BioScrip, Inc.
Craig Allison
Director, Corporate Communications
Tel: 914-460-1636
callison@BioScrip.com
or
In-Site Communications
Lisa M. Wilson
Tel: 917-543-9932
lwilson@insitecony.com

Copyright Business Wire 2008
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.